Clcn7 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Hatnote|For the chloride channel protein, see ClC-7 Chloride Channel}}
CLCN7 (Chloride Voltage-Gated Channel 7) encodes ClC-7, a late endosomal and lysosomal chloride channel critical for bone resorption and lysosomal function. Mutations cause severe bone and neurological disorders.
CLCN7 Gene is involved in biological pathways relevant to neurodegenerative diseases. It plays important roles in neuronal function, cellular signaling, ion transport, protein homeostasis, or stress response mechanisms.
Dysregulation or mutations in this gene contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders.
| Attribute | Value |
|---|---|
| Gene Symbol | CLCN7 |
| Full Name | Chloride Voltage-Gated Channel 7 |
| Chromosomal Location | 16p13.3 |
| NCBI Gene ID | 1191 |
| OMIM | 602727 |
| Ensembl ID | ENSG00000132449 |
| UniProt | P51797 |
| Associated Diseases | Osteopetrosis, Autosomal Dominant Osteopetrosis, Lysosomal Storage Disease |
The CLCN7 gene encodes ClC-7, a chloride channel that resides in the membrane of late endosomes and lysosomes. It is critical for proper acidification of these organelles and works in concert with the V-ATPase to enable lysosomal function.
The study of Clcn7 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.